Back to Trades
Other4
Kailera Therapeutics, Inc.
KLRA
Total Value
$9.6M
Company Information
- Company Name
- Kailera Therapeutics, Inc.
- Ticker Symbol
- KLRA
- CIK
- 0002096997
Insider Information
- Role
- Insider
- Location
- WALTHAM, MA
Filing Details
- Filing Date
- Apr 20, 2026
- Transaction Date
- Apr 16, 2026
- Accession Number
- 0001193125-26-164299
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | Derivative | 300,000 | $16.00 | Grant/Award | $4.8M |
| Apr 16, 2026 | Derivative | 300,000 | $16.00 | Grant/Award | $4.8M |
Footnotes
- (F1)The options vest and become exercisable as to 25% of the underlying shares on April 16, 2027 and thereafter in 36 substantially equal monthly installments, subject to the Reporting Person's continued service through each such vesting date.
- (F2)The options vest and become exercisable, if at all, as to all of the underlying shares if (i) the average daily closing price of the Company's common stock on Nasdaq during any 30 consecutive calendar-day period during the period beginning October 16, 2026 and ending on April 16, 2030 (the "Performance Measurement Period"), or (ii) the stock price in a change in control transaction that occurs during the Performance Measurement Period, equals or exceeds $40 per share, in each case subject to the Reporting Person's continued service through such vesting date.